PEI transfection of HEK cells
Split the cells 1:5 into 10 cm plate (on 21.04.17)
Thaw PEI reagent at RT
Dilute plasmid in 1 ml serum free DMEM (2.5µg from each plasmid)
Add 15 µl PEI(1µg/µl) to the mix while vortexing (PEI:DNA=3:1)
incubate 15 min at RT
Add the mix to the culture
13.05.17
PEI transfection of HEK, Jurkat, HPB-ALL and HUT78 cells
Split cells 1:5 to a 6-well plate: 100 µl/well (on 12.05.17)
For each sample: 3 µg plasmid DNA + 200 µl serum free DMEM
Establish Mastermix
Add 9 µg PEI to each mix while vortexing (PEI:DNA=3:1)
15 min incubation
Add the Mix to the cells: 275.25 µl GFP-Mix or 215.5 µl to corresponding samples
After 48h: Fluorescence Microscopy
Plasmid number | component | concentration[ng/µL] | volume[µL] for 12 µg |
pIG17_008 | CMV_mCherry-delta-PstI_pA | 471.5 | 25 |
pIG17_009 | CMV_EGFP_pA | 368.4 | 30 |
23.05.17
PEI transfection of HEK, Jurkat, HPB-ALL and HUT78 cells
Plasmid number | component |
pIG17_008 | CMV_mCherry-delta-PstI_pA |
pIG17_009 | CMV_EGFP_pA |
Split cells 1:5 to a 6-well plate: 330 µl (from 10 cm plate)/well (22.05.17)
For each sample: 3 µg plasmid DNA + 200 µl serum free DMEM
Establish Mastermix
Add PEI to each mix while vortexing (PEI:DNA=3:1)
15 min incubation
Add the Mix to the cells
After 48h: Fluorescence Microscopy & Flow Cytometry
Lipotransfection of Jurkat, HPB-ALL and HUT78 cells
Plasmid number | component |
pIG17_009 | CMV_EGFP_pA |
pGFP: 2.5 µg/well
Mix I: 150 µl serum free DMEM and 6 µl LTX reagent
Mix II: 700 µl SERUM FREE DMEM + 2.5 µg pGFP + 14 µl PLUS reagent
Mix 150 µl Mix I with 150 µl Mix II
5 min incubation at RT
Add 300 µl to cells
30.05.17
BioRad electroporation
Cell lines: HPB-ALL, HUT78 and Jurkat
Plasmid: pIG17_009 (GFP plasmid)
Count the cells
Transfer 1 mio. cells into falcons and centrifuge with 100g for 3 min
Resuspend the cell pellet with 100 µl P3 Buffer
Add 3 µg pIG17_009
Transfer the mixture into cuvette
BioRad setting: 250 V, 960 µF, 35 sec.
Add 500 µl RPMI medium to the cells immediately after electroporation
Plate the cells into 12-well plate with 2 ml Medium
Over night culturing
Wash the cuvettes for reusing
05.06.17
preparation for lentiviral transduction
Plate 4 mio. Hek cells in 10 cm plate. (Will be around 7-8 mio cell the next day)
(optional: 5-6 mio. Hek cells in 15 cm plate)
06.06.17
Production of Lentivirus
Transfection of HEK cells for virus production.
Lentiviral packaging cells | Hek293T cells |
Plate size | 10 cm |
Total DNA/plate | 12.87 µg |
Transfer: gag/pol: env ratio | 2:1:1 |
Construct | 6.43 µg |
pCMV∆R8.74 | 3.22 µg |
pMD2G | 3.22 µg |
N/P ration | 15 |
Plasmid number | component | concentration[ng/µL] | volume [µL] |
pIG17_082 | Transfer plasmid with GFP p526 | 253 | 25.4 |
pIG17_003 | Envelope plasmid pMD2G | 105 | 30.7 |
pIG17_004 | Packaging Plasmid pCMV∆R8.74 | 150 | 21.5 |
Component | 1x [µL] | 2.1x [µL] |
pIG17_003 | 30.63 | 45.03 |
pIG17_004 | 21.44 | 64.33 |
150mM NaCl | 441.49 | 927.12 |
total | 493.56 | 1036.476 |
Component | 1x [µL] | 2.1x [µL] |
23.2mM (1 µg/µl)PEI | 24.94 | 52.41 |
150mM NaCl | 475.04 | 997.59 |
total | 499.98 | 1050 |
07.06.17
Amaxa electroporation
Cell lines: HUT78 and Jurkat
Plasmid: pIG17_008 (mCherry plasmid)
Count the cells
Transfer 1 mio. cells into falcons and centrifuge with 100g for 3 min
Resuspend the cell pellet with 100 µl P3 Buffer
Add 3 µg pIG17_008
Transfer the mixture into cuvette
Amaxa Programm: X-005
Add 500 µl RPMI medium to the cells immediately after electroporation
Plate the cells into 12-well plate with 2 ml Medium
Over night culturing
Wash the cuvettes for reusing
Production of Lentivirus
BioRad electroporation
Cell lines: HUT78 and Jurkat
Plasmid: pIG17_009 (GFP plasmid)
Count the cells
Transfer 1 mio. cells into falcons and centrifuge with 100g for 3 min
Resuspend the cell pellet with 100 µl P3 Buffer
Add 3 µg pIG17_009
Transfer the mixture into cuvette
BioRad setting: 250 V, 960 µF, 35 sec.
Add 500 µl RPMI medium to the cells immediately after electroporation
Plate the cells into 12-well plate with 2 ml Medium
Over night culturing
Wash the cuvettes for reusing
08.06.17
Production of Lentivirus
Flow Cytometry
negative controls: Hut78 and Jurkat cells.
positive control: GFP_Jurkat(p526)
Amaxa Samples: Hut78 (mCherry and GFP) and Jurkat (mCherry)
BioRad Samples: Hut78 (GFP) and Jurkat (GFP)
Count the cells
resuspend cell pellet (about 1 mio.) with FACS Buffer (PBS with 1%FCS)
09.06.17
Lentiviral transduction
Plate about 200000 cells for each wells.
Incubate the plates over weekend in incubator.
Jurkat sample | Medium [ml] | Virus [ml] |
1 | 1 | 1 |
2 | 0 | 2 |
Hut78 sample | Medium [ml] | Virus [ml] |
1 | 2 | 0 |
2 | 1.5 | 0.5 |
3 | 1 | 1 |
4 | 0 | 2 |
HEK sample | Medium [ml] | Virus [ml] |
1 | 2 | 0 |
2 | 1.5 | 0.5 |
3 | 1 | 1 |
4 | 0 | 2 |
10.06.17
BioRad electroporation
Component | Amount |
Hut cells | 3 mio. cells |
pIG17_008 | 5 µg |
Setting | Capacitance[µF] | Voltage | Cuvette size[cm] | Time Constance [msec] |
Setting 1 | 250 | 150 | 0.2 | 4.0 |
Setting 2 | 500 | 120 | 0.2 | 10.1 |
12.06.17
Lentiviral transduction
After 72h → Change the medium of the plates (for suspension cells: first centrifuge and then resuspend cell pellet with new medium)
Incubation over night for FACS
Flow Cytometry for BioRad electroporation on June 10th
13.06.17
Flow Cytometry for lentiviral infected cells
with ration of 1:1 (Medium vs. Virus medium) cells were most frequently infected and viable.
BioRad Electroporation
Cell type | Setting | Capacitance[µF] | Voltage | resistence | Time Constance [msec] |
Jurkat | Setting 1 | 300 | 250 | ∞ | 35 |
Jurkat | Setting 2 | 350 | 200 | 1000Ω | 35 |
Hut78 | Setting 1 | 250 | 150 | ∞ | 50 |
Hut78 | Setting 2 | 500 | 120 | ∞ | 50 |
14.06.17
Amaxa electroporation
Flow Cytometry for BioRad electroporated JK cells
No positive cell population.
15.06.17
Flow Cytometry for BioRad electroporated Hut78 cells and Amaxa electroporated T cells
no positive cell population.
16.06.17
Mycoplasma test(lentiviral transduced Jurkat and Hut78)
Jurkat(p526): mycoplasma positive
Hut78(p526):mycoplasma positive
HEK(p526): mycoplasma negative
No cell sorting, stock cultures should be sent for test.
17.06.17
BioRad Electroporation with JK cells
Approach | Capacitance[µF] | Voltage | Cuvette size[cm] | Time Constance [msec] |
1:negative control | 960 | 250 | 0.2 | 35 |
2:condition 1 | 960 | 250 | 0.2 | 35 |
3:condition 2 | 960 | 250 | 0.2 | 35 |
4:condition 3 | 960 | 250 | 0.2 | 40 |
PEI transfection with HEK cells
4 approaches:
1 transfection with pIG17_009
2 transfections with pIG17_013
1 untransfected as control
Split cells 1:5 to a 6-well plate: 100 µl/well (on 16.06.17)
For each sample: 3 µg plasmid DNA + 200 µl serum free DMEM
Establish Mastermix
Add 9 µg PEI to each mix while vortexing (PEI:DNA=3:1)
15 min incubation
Add the Mix to the cells
After 48h: Fluorescence Microscopy & Flow cytometry
Plasmid number | component |
pIG17_013 | pHRE_Ptal_EGFP_pA |
19.06.17
Hypoxia test (CoCl2)
Cell: via PEI transfected HEK cells.
CoCl2 stock: 1M
End concentration of CoCl2: 100µM
Cell observation under fluorescence microscopy after 2h:
-By adding CoCl2, the HRE-GFP transfected cells showed less fluorescence signal than without CoCl2…
BioRad Electroporation
Approach | Capacitance[µF] | Voltage | Cuvette size[cm] | Time Constance [msec] |
1:negative control | 960 | 250 | 0.2 | 35 |
2:condition1 | 960 | 250 | 0.2 | 35 |
3:condition2 | 960 | 250 | 0.2 | 30 |
4:condition3 | 960 | 250 | 0.2 | 40 |
20.06.17
BioRad electroporation
Cell lines: Jurkat
Plasmid: pIG17_009
Cell count: 2 mio./ approach
Setting: 96 well plates, well set 1(ABCD1), Expotential
4 approaches:
Approach | Capacitance[µF] | Voltage | Cuvette size[cm] | Resistance |
1:negative control | 950 | 250 | 0.2 | 1000Ω |
2:condition1 | 350 | 250 | 0.2 | ∞ |
3:condition2 | 300 | 300 | 0.2 | 1000Ω |
4:condition3 | 300 | 250 | 0.2 | 1000Ω |
21.06.17
Mycoplasma-Test (Stock cultures)
HEK293T: mycoplasma negative
Jurkat: mycoplasma negative
Hut78: mycoplasma positive → abort culturing of Hut78!
Flow Cytometry (BioRad on Jun.19th)
24.06.17
PEI transfection (pIG17_013) for hypoxia test
Split the cells 1:5 into 10 cm plate (on 23.06.17)
Thaw PEI reagent at RT
Dilute plasmid in 1 ml serum free DMEM (3µg from each plasmid)
Add 15 µl PEI(1µg/µl) to the mix while vortexing (PEI:DNA=3:1)
incubate 15 min at RT
Add 200µl mix to wells
25.06.17
Hypoxia test (CoCl2)
Well | End concentration of CoCl2[µM] | Volume of Stock CoCl2[µl] |
1: untransfected | 100 | 200 |
2:pIG17_009 transfected | - | - |
3:pIG17_013 transfected | - | - |
4:pIG17_013 transfected | 50 | 100 |
5:pIG17_013 transfected | 100 | 200 |
6:pIG17_013 transfected | 200 | 400 |
* Cell observation under fluorescence microscopy every hour after CoCl2 treatment
BioRad Electroporation
Approach | Capacitance[µF] | Voltage | Resistance | Time Constance [msec] |
1:3 µg plasmid | 960 | 250 | ∞ | 20 |
2:6 µg plasmid | 960 | 250 | ∞ | 20 |
3:9 µg plasmid | 960 | 250 | ∞ | 20 |
26.06.17
Hypoxia test (CoCl2)
1.Plate
Duration of Treatment | Well | End concentration of CoCl2[µM] | Volume of Stock CoCl2[µl] |
6h | 1: untransfected | 100 | 200 |
6h | 2:pIG17_009 transfected | - | - |
6h | 3:pIG17_013 transfected | - | - |
6h | 4:pIG17_013 transfected | 50 | 100 |
6h | 5:pIG17_013 transfected | 100 | 200 |
6h | 6:pIG17_013 transfected | 200 | 400 |
2.Plate
Duration of Treatment | Well | End concentration of CoCl2[µM] | Volume of Stock CoCl2[µl] |
24h | 1: untransfected | 100 | 200 |
24h | 2:pIG17_009 transfected | - | - |
24h | 3:pIG17_013 transfected | - | - |
24h | 4:pIG17_013 transfected | 50 | 100 |
24h | 5:pIG17_013 transfected | 100 | 200 |
24h | 6:pIG17_013 transfected | 200 | 400 |
Flow Cytometry (Hypoxia test & BioRad)
Hypoxia test
No induction of GFP expression under hypoxia condition
Problems:
BioRad Electroporation
By increasing the amount of plasmid DNA, some cells were potentially transfected!!!
27.06.17
BioRad Electroporation
GFP Plasmid: pIG17_009
Approach | Capacitance[µF] | Voltage | Resistance | Time Constance [msec] |
1 | 950 | 250 | ∞ | 20 |
2 | 950 | 250 | 1000Ω | 20 |
3 | 950 | 250 | 1500Ω | 20 |
Knock out
Approach | Plasmid | Capacitance[µF] | Voltage | Resistance | Time Constance [msec] |
1 | 203 (Cas9) + 104 (gRNA) | 950 | 250 | ∞ | 20 |
2 | 203 (Cas9)+ scramble | 950 | 250 | ∞ | 20 |
3 | sgRNA3 (gRNA_GFP) | 950 | 250 | ∞ | 20 |
4 | sgRNA3 (gRNA_GFP) | 950 | 250 | ∞ | 20 |
28.06.17
Flow Cytometry: electroporation on June 27th
29.06.17
Production of Lentivirus
Transfection of HEK cells for virus production.
Lentiviral packaging cells | Hek293T cells |
Plate size | 10 cm |
Total DNA/plate | 12.87 µg |
Transfer: gag/pol: env ratio | 2:1:1 |
Construct | 6.43 µg |
pCMV∆R8.74 | 3.22 µg |
pMD2G | 3.22 µg |
N/P ration | 15 |
Plasmid number | component | concentration[ng/µL] | volume [µL] |
pIG17_? | LentiCRISPR(AG Cathomen) | 1100 | 5.85 |
pIG17_003 | Envelope plasmid pMD2G | 68 | 47.4 |
pIG17_004 | Packaging Plasmid pCMV∆R8.74 | 209 | 15.4 |
Component | 1x [µL] | 2.1x [µL] |
pIG17_003 | 47.4 | 99.54 |
pIG17_004 | 15.4 | 32.34 |
150mM NaCl | 441.49 | 927.12 |
total | 504.3 | 1059 |
Component | 1x [µL] | 2.1x [µL] |
23.2mM (1µg/µl)PEI | 24.94 | 52.41 |
150mM NaCl | 475.04 | 997.59 |
total | 499.98 | 1050 |
30.06.17
Production of Lentivirus
01.07.17
Production of Lentivirus
Lentiviral transduction
Plate about 200000 cells for each wells.
Incubate the plates over weekend in incubator.
Jurkat sample | Medium [ml] | Virus [ml] |
1 | 2 | 0 |
2 | 1.5 | 0.5 |
3 | 1 | 1 |
4 | 0.5 | 1.5 |
5 | 0 | 2 |
PEI transfection with HEK for Hypoxia Test
well | plasmid |
1 | - |
2 | pIG17_009 |
3 | pIG17_013 |
4 | pIG17_013 |
5 | pIG17_013 |
6 | pIG17_013 |
BioRad Electroporation: Repeat pGFP transfection
9µg for each approach
Approach | Capacitance[µF] | Voltage | Resistance | Time Constance [msec] |
1: no plasmid | 950 | 250 | ∞ | 20 |
2: Mock plasmid | 950 | 250 | ∞ | 20 |
3: pIG17_009 | 950 | 250 | ∞ | 20 |
4: pIG17_009 | 950 | 250 | 1000Ω | 20 |
5: pIG17_009 | 950 | 250 | 1500Ω | 20 |
02.07.17
CoCl2 treatment with Jurkat cells
Repeat Hypoxia test (24h after PEI)
No induction of GFP expression under hypoxia condition
Add different concentrations of CoCl2 (50µM, 100µM and 200 µM)
Observe the cells under fluorescence microscope 3h, 6h, 8h, 16h, 18h and 24h after CoCl2 treatment
No detectable induction of gene expression for every approach
Flow Cytometry (BioRad on July 1st)
03.07.17
Repeat Hypoxia test (48h after PEI)
No induction of GFP expression under hypoxia condition
Add different concentrations of CoCl2 (50µM, 100µM and 200 µM)
Observe the cells under fluorescence microscope 3h, 6h, 8h, 16h, 18h and 24h after CoCl2 treatment
No detectable induction of gene expression for every approach
04.07.17
Lentiviral transduction (pLenti-CRISPR from AG Cathomen)
BioRad Electroporation: Repeat pGFP transfection
9µg for each approach
Approach | Capacitance[µF] | Voltage | Resistance | Time Constance [msec] |
1: no plasmid | 950 | 250 | ∞ | 20 |
2: Mock plasmid | 950 | 250 | ∞ | 20 |
3: pIG17_009 | 950 | 250 | ∞ | 20 |
4: pIG17_009 | 950 | 250 | 500Ω | 20 |
5: pIG17_082 (p526) | 950 | 250 | ∞ | 20 |
05.07.17
In total: 3*6 wells
Transfection with pIG17_009 as positive control: 1 well
Transfection with pIG17_022: 4 wellS
Transfection with pIG17_023: 4 wellS
Per Approach: 3µg DNA, 200µl serum free DMEM and 9µg PEI
Split the cells 1:5 into 10 cm plate (on 03.07.17)
Thaw PEI reagent at RT
Dilute plasmid in 200µl serum free DMEM (3µg from each plasmid)
Add PEI(1µg/µl) to the mix while vortexing (PEI:DNA=3:1)
incubate 15 min at RT
Add 200µl mix to wells
Flow Cytometry
06.07.17
Prepare cells for lentivirus-production
VEGF induction with Modeling group
07.07.17
Lentivirus(pIG17_119) production in HEK cells
Transfection of HEK cells for virus production.
Lentiviral packaging cells | Hek293T cells |
Plate size | 10 cm |
Total DNA/plate | 12.87 µg |
Transfer: gag/pol: env ratio | 2:1:1 |
Construct | 6.43 µg |
pCMV∆R8.74 | 3.22 µg |
pMD2G | 3.22 µg |
N/P ration | 15 |
Plasmid number | component | concentration[ng/µL] | volume [µL] |
pIG17_119 | pCRE_GFP_CMV_mCherry | 167 | 38.5 |
pIG17_003 | Envelope plasmid pMD2G | 243.4 | 13.3 |
pIG17_004 | Packaging Plasmid pCMV∆R8.74 | 819 | 4 |
Component | 1x [µL] | 2.1x [µL] |
pIG17_003 | 13.3 | 28 |
pIG17_004 | 4 | 8.4 |
150mM NaCl | 441.49 | 927.12 |
total | 458.8 | 963.52 |
Component | 1x [µL] | 2.1x [µL] |
23.2mM (1µg/µl)PEI | 24.94 | 52.41 |
150mM NaCl | 475.04 | 997.59 |
total | 499.98 | 1050 |
08.07.17
Lentivirus(pIG17_119) production in HEK cells
BioRad electroporation
4 Approaches (9µg/Approach)
Setting: 12 well plate, 1 well set, 1 Pulse, ∞ Resistance
Electroporated without plasmid
CMV-GFP from Nicole (700 ng/µl)
CMV-GFP (Yael, 06.06.17, 140.4 ng/µl)
CMV-GFP (Dennis, 27.06.17, Dennis, 86.8 ng/µl)
09.07.17
Lentivirus(pIG17_119) production in HEK cells
Collect virus medium
Add new medium
10.07.17
Lentivirus(pIG17_119) production in HEK cells
Collect virus medium
Add new medium
11.07.17
PEI transfection (CTLA-4 Test)
In total: 3*6 wells
Transfection with pIG17_009 as positive control: 1 well (plasmid from Nicole); 1 well (Culture from Nicole, from us preped using promega miniprep)
Transfection with pIG17_022: 5 wellS
Transfection with pIG17_023: 5 wellS
Per Approach: 3µg DNA, 200µl serum free DMEM and 9µg PEI
Split the cells 1:5 into 10 cm plate (on 03.07.17)
Thaw PEI reagent at RT
Dilute plasmid in 200µl serum free DMEM (3µg from each plasmid)
Add PEI(1µg/µl) to the mix while vortexing (PEI:DNA=3:1)
incubate 15 min at RT
Add 200µl mix to wells
Lentiviral transduction (pIG17_119) of Jurkat cells
The cells were not successfully infected.
12.07.17
BioRad electroporation
Approach | plasmid | Capacitance[µF] | Voltage | Resistance | Time Constance [msec] |
1 | no plasmid | 950 | 250 | ∞ | 20 |
2 | CMV-GFP (Nicole) | 950 | 250 | ∞ | 20 |
3 | CMV-GFP (Culture from Nicole, promega mini) | 950 | 250 | ∞ | 20 |
4 | pIG17_104: Cas9-GFP-gRNA3 | 950 | 250 | ∞ | 20 |
14.07.17
Lentivirus(pIG17_121) production in HEK cells
Transfection of HEK cells for virus production.
Lentiviral packaging cells | Hek293T cells |
Plate size | 10 cm |
Total DNA/plate | 12.87 µg |
Transfer: gag/pol: env ratio | 2:1:1 |
Construct | 6.43 µg |
pCMV∆R8.74 | 3.22 µg |
pMD2G | 3.22 µg |
N/P ration | 15 |
Plasmid number | component | concentration[ng/µL] | volume [µL] |
pIG17_121 | pCTLA4(380)_GFP_CMV_mCherry | 1682 | 3.82 |
pIG17_003 | Envelope plasmid pMD2G | 321.9 | 10 |
pIG17_004 | Packaging Plasmid pCMV∆R8.74 | 819 | 4 |
Component | 1x [µL] | 2.1x [µL] |
pIG17_003 | 10 | 21 |
pIG17_004 | 4 | 8.4 |
150mM NaCl | 441.49 | 927.12 |
pIG17_121 | 3.82 | 8 |
total | 504.95 | 1060 |
Component | 1x [µL] | 2.1x [µL] |
23.2mM (1µg/µl)PEI | 24.94 | 52.41 |
150mM NaCl | 475.04 | 997.59 |
total | 499.98 | 1050 |
BioRad electroporation
Approach | plasmid | Capacitance[µF] | Voltage | Resistance | Time Constance [msec] |
1 | no plasmid | 950 | 250 | ∞ | 20 |
2 | 6µg Cas9-GFP-gRNA3 | 950 | 250 | ∞ | 20 |
3 | 9µg Cas9-GFP-gRNA3 | 950 | 250 | ∞ | 20 |
4 | 12µg Cas9-GFP-gRNA3 | 950 | 250 | ∞ | 20 |
15.07.17
collect virus (pIG17_121)
flow cytometry (BioRad 7/14)
16.07.17
PEI transfection
In total: 3*6 wells
One well with non-transfected cells
Transfection with CMV-GFP as positive control: 1 well (JetStar); 1 well (Promega Mini)
Transfection with pIG17_013: 4 wellS
Per Approach: 3µg DNA, 200µl serum free DMEM and 9µg PEI
Split the cells 1:5 into 6-well plate (on 15.07.17)
Thaw PEI reagent at RT
Dilute plasmid in 200µl serum free DMEM (3µg from each plasmid)
Add PEI(1µg/µl) to the mix while vortexing (PEI:DNA=3:1)
incubate 15 min at RT
Add 200µl mix to wells
BioRad electroporation
Approach | plasmid | Capacitance[µF] | Voltage | Resistance | Time Constance [msec] |
1 | no plasmid | 950 | 250 | ∞ | 20 |
2 | CMV-GFP JetStar | 950 | 250 | ∞ | 20 |
3 | CMV-GFP promega mini | 950 | 250 | ∞ | 20 |
4 | CMV-mCherry (Nicole) | 950 | 250 | ∞ | 20 |
5 | pIG17_008 (Jana) | 950 | 250 | ∞ | 20 |
17.07.17
Hypoxia Test in hypoxia incubator (AG Cathomen)
Flow Cytometry
18.07.17
Hypoxia Test in hypoxia incubator (AG Cathomen)
Lentiviral transduction
BioRad electroporation
Approach | plasmid | Capacitance[µF] | Voltage | Resistance | Time Constance [msec] |
1 | pIG17_119 | 950 | 250 | ∞ | 20 |
2 | pIG17_121 | 950 | 250 | ∞ | 20 |
3 | pIG17_031 | 950 | 250 | ∞ | 20 |
4 | pIG17_034 | 950 | 250 | ∞ | 20 |
5 | pIG17_037 | 950 | 250 | ∞ | 20 |
5 | pIG17_086 | 950 | 250 | ∞ | 20 |
PEI transfection (CTLA-4 Test)
In total: 2*12 wells
One well with non-transfected cells
One well: Transfection with CMV-GFP as positive control
Transfection with pIG17_022: 5 wellS
Transfection with pIG17_023: 5 wellS
Transfection with pIG17_037: 5 wellS
Transfection with pIG17_086: 5 wellS
Per Approach: 1.5µg DNA, 100µl serum free DMEM and 4.5µg PEI
Split the cells 1:10 into 12-well plate (on 17.07.17)
Thaw PEI reagent at RT
Dilute plasmid in 100µl serum free DMEM (3µg from each plasmid)
Add PEI(1µg/µl) to the mix while vortexing (PEI:DNA=3:1)
incubate 15 min at RT
Add 100 µl mix to wells
PEI transfection (hypoxia test with CoCl2)
In total: 4*6-well plates
One well in each plate: with non-transfected cells
One well in each plate: Transfection with CMV-GFP as positive control
Transfection with pIG17_013: 8 wellS
Transfection with pIG17_031: 8 wellS
Split the cells 1:10 into 6-well plate (on 17.07.17)
Thaw PEI reagent at RT
Dilute plasmid in 100µl serum free DMEM (3µg from each plasmid)
Add PEI(1µg/µl) to the mix while vortexing (PEI:DNA=3:1)
incubate 15 min at RT
Add 200 µl mix to wells
19.07.17
Concentrate the viruses (pIG17_119 and pIG17_121)
for 20 ml virus medium, use 5ml 20% sucrose
carefully add virus medium to sucrose (very tricky)
centrifuge at 4000 rpm over night
After centrifugation: remove the medium, put the falcon tube upside down and air dry.
slowly add 100 µl PBS (20-30x, also very tricky)
Incubate the pellet for 30-60 min
resuspend the cells 2x
aliquot the virus
store in -80°C freezer
Lentiviral transduction
CoCl2 treatment (24h after PEI)
Treatment with 2*6 well plate: 1 with pIG17_013 and 1 with pIG17_031
Make new 2M CoCl2 stock
add CoCl2 to the cells, end-concentration: 0, 300µM, 500µM and 100µM
Incubation for 24h and track the induction of cell expression
Hypoxia Test in hypoxia incubator (AG Cathomen)
Flow Cytometry (BioRad on July 20th)
20.07.17
CoCl2 treatment (48h after PEI)
Treatment with 2*6 well plate: 1 with pIG17_013 and 1 with pIG17_031
Make new 2M CoCl2 stock
add CoCl2 to the cells, end-concentration: 0, 300µM, 500µM and 100µM
Incubation for 24h and track the induction of cell expression
Hypoxia Test in hypoxia incubator (AG Cathomen)
21.07.17
BioRad Electroporation (Knock-Out plasmids)
Approach | plasmid | Capacitance[µF] | Voltage | Resistance | Time Constance [msec] |
1 | - | 950 | 250 | ∞ | 20 |
2 | CMV-GFP (#503 from Nicole) | 950 | 250 | ∞ | 20 |
3 | pIG17_082 (p526) | 950 | 250 | ∞ | 20 |
4 | Cas9-GFP-gRNA5 | 950 | 250 | ∞ | 20 |
5 | Cas9-GFP-scramble | 950 | 250 | ∞ | 20 |
22.07.17
Lentivirus(pIG17_119 and pIG17_121) production in HEK cells
PEI Transfection of HEK cells for virus production.
Lentiviral packaging cells | Hek293T cells |
Plate size | 10 cm |
Total DNA/plate | 12.87 µg |
Transfer: gag/pol: env ratio | 2:1:1 |
Construct | 6.43 µg |
pCMV∆R8.74 | 3.22 µg |
pMD2G | 3.22 µg |
N/P ration | 15 |
Plasmid number | component | concentration[ng/µL] | volume [µL] |
pIG17_119 | pCRE_GFP_CMV_mCherry | 167 | 38 |
pIG17_121 | pCTLA4(380)_GFP_CMV_mCherry | 1682 | 3.82 |
pIG17_003 | Envelope plasmid pMD2G | 105 | 30.7 |
pIG17_004 | Packaging Plasmid pCMV∆R8.74 | 208 | 15.5 |
Component | 1x [µL] | 2.1x [µL] |
pIG17_003 | 30.7 | 64.5 |
pIG17_004 | 15.5 | 32.6 |
150mM NaCl | 441.49 | 927.12 |
Component | 1x [µL] | 2.1x [µL] |
23.2mM (1µg/µl)PEI | 24.94 | 52.41 |
150mM NaCl | 475.04 | 997.59 |
total | 499.98 | 1050 |
22.07.17
Flow Cytometry: BioRad Electroporation 7/21
there was GFP positive signals during flow cytometry measurement but the cells were mycoplasma positive
Lentivirus(pIG17_119 and pIG17_121) production in HEK cells
23.07.17
Lentivirus(pIG17_119 and pIG17_121) production in HEK cells
24.07.17
Mycoplamsa Test
25.07.17
PEI transfection of CHO cells: Hypoxia & Tet system
Split the cells 1:2 in 12-well plate (on 24.07.17)
Per Approach: 1µg DNA + 8µg PEI and fill up to 100 µl with serum free DMEM
Thaw PEI reagent at RT
Add PEI(1µg/µl) to the mix while vortexing
incubate 15 min at RT
Add the mix to cells
Plasmid | Approach | DNA Concentration[ng/µl] | DNA volume | Volume of DMEM[µl] |
CMV-GFP (#503 from Nicole) | 1 | 25.5 | 40 | 52 |
CMV-mCherry (AG Hiltbrunner) | 1 | 1200 | 1 | 91 |
pIG17_012 | 6 | 253 | 24 | 528 |
pIG17_013 | 6 | 583.3 | 10.3 | 541.7 |
pIG17_031 | 6 | 746.9 | 8 | 544 |
Tet-GFP (Shima) | 2 (protocol from Shima) | 520 | 3.8 | 180.2 |
Tet-GFP (Shima) | 2 (our protocol) | 520 | 5.8 | 200 |
Tetracycline induction of CHO
3h after PEI transfection: remove media, add tetracycline to new media (1:1000 dilution)
Tetracycline Stock: 2mg/ml (End: 1µg per well of 12-well plate)
3h after adding tetracycline: no induction
incubation till the next day: microscopic observation
Gene expression was induced by tetracycline compared to the tetracycline-untreated cells
PEI transfection of HEK cells: Hypoxia
Split the cells 1:5 in 12-well plate (on 24.07.17)
Per Approach: 1.5µg DNA + 4.5µg PEI and 100 µl serum free DMEM
Thaw PEI reagent at RT
Add PEI(1µg/µl) to the mix while vortexing
incubate 15 min at RT
Add the mix to cells
Plasmid | Approach | DNA Concentration[ng/µl] | DNA volume |
CMV-GFP (#503 from Nicole) | 1 | 25.5 | 59 |
CMV-mCherry (AG Hiltbrunner) | 1 | 1200 | 1.25 |
pIG17_012 | 6 | 131.4 | 12 |
pIG17_013 | 6 | 583.3 | 15.5 |
pIG17_031 | 6 | 746.9 | 12 |
26.07.17
CoCl2 treatment
Endconcentration of CoCl2[µM] | Volume from Stock[µl] |
0 | 0 |
100 | 0.1 |
200 | 0.2 |
300 | 0.3 |
500 | 0.5 |
1000 | 1 |
27.07.17
SEAP assay with HEK cells
- gather 200 µl of cell supernatant
- incubate cell supernatant at 65°C for 30min
- centrifuge cell supernatant for 1 min at 1250g
- add 150 µl supernatant into a cuvette
- add 500 µl 2x SEAP buffer
- add 100 µl pNPP and remove bubbles carefully
- measure in a nano drop every 5min for 2h
31.07.17
Mycoplasma Test: New HEK stock
01.08.17
BioRad Electroporation
Approach | plasmid | Capacitance[µF] | Voltage | Resistance | Time Constance [msec] |
1 | pIG17_009 (06.06 Yael) | 950 | 250 | ∞ | 20 |
2 | Cas9-GFP-gRNA5 | 950 | 250 | ∞ | 20 |
3 | Cas9-GFP-scramble | 950 | 250 | ∞ | 20 |
4 | KO-Kit: 203+101 | 950 | 250 | ∞ | 20 |
5 | KO-Kit: 203+104 | 950 | 250 | ∞ | 20 |
6 | KO-Kit scramble | 950 | 250 | ∞ | 20 |
PEI transfection: Hypoxia - SEAP assay in HEK cells
Plasmid number | component | concentrations of the used tubes[ng/µL] | volumes from the used tubes[µL] for 36µg |
pIG17_013 | HRE-SEAP | 583.3 and 88.1 | 55.7 and 40 |
pIG17_002 | CMV-SEAP | 92.0 and 91.4 | 350 and 41.6 |
Due to the concentrations and volumes in the tubes for each approach two were used.
Per construct 24 wells were used.
Each well will have different CoCl2 concentrations. For each approach triplicates will be analysed.
02.08.17
Flow Cytometry of BioRad Electroporation (8/1): KO plasmids
For the knockout Kit we could see the most living GFP positive cells (26.2%) for the cotransfection of 203 and 104.
The Cas9 GFP guide RNA5 had 5.21% GFP positive cells under the gated living cells.
Addition of CoCl2: Hypoxia - SEAP assay in HEK cells
1:10 dilution of a 2M CoCl2 stock with PBS. CoCl2 was added to HRE-SEAP approaches in order to induce the promoter, as well as to CMV-SEAP approaches
Approaches:
For each approach triplicates were done.
CoCL2 concentration[µM] | volume[µL] of 200mM CoCl2 |
0 | 0 |
100 | 0.55 |
150 | 0.825 |
200 | 1.1 |
250 | 1.375 |
300 | 1.65 |
500 | 2.75 |
1000 | 5.5 |
Lentivirus production in HEK cells: Mock, Knock-down plasmid (114,115,116), pIG17_119, pIG17_121
Follow the protocol from Frederike (AG Schamel)
PEI Transfection of HEK cells for virus production.
Prepare packaging and PEI mix separately and incubate for 10 min
Mix packaging mix with transferplasmid
Add PEI mix to DNA mix and incubate for 15 min
Add the PEI+DNA mix to cells
Lentiviral packaging cells | Hek293T cells |
Plate size | 10 cm |
Total DNA/plate | 12.87 µg |
Transfer: gag/pol: env ratio | 2:1:1 |
Construct | 6.43 µg |
pCMV∆R8.74 | 3.22 µg |
pMD2G | 3.22 µg |
N/P ration | 15 |
Plasmid number | component | No. of Approaches | concentration[ng/µL] | volume [µL] |
pIG17_082 | Mock(p526):EF1-GFP | 2 | 68 | 189.1 |
pIG17_114 | Knock-down plasmid | 2 | 350; 432 | 18.4; 15 |
pIG17_115 | Knock-down plasmid | 1 | - | all two tubes |
pIG17_116 | Knock-down plasmid | 2 | 492; 356 | 20; 8.5 |
pIG17_003 | Envelope plasmid pMD2G | 7 | 150;68.7;63.7 | 30;180;80 |
pIG17_004 | Packaging Plasmid pCMV∆R8.74 | 7 | 926.6 | 24.3 |
Component | 7x [µL] |
pIG17_003 | 290 |
pIG17_004 | 24.3 |
150mM NaCl | 3090.43 |
Follow our protocol of PEI transfection
DNA:PEI ratio = 1:8
Mix DNA with 1 ml serum free DMEM
Add PEI while vortexing
15 min incubation
Component | Mass/approach[µg] |
pIG17_003 | 3.2 |
pIG17_004 | 3.2 |
pIG17_119 | 6.4 |
pIG17_121 | 6.4 |
03.08.17
Hypoxia - SEAP assay in HEK cells
- gather 200 µl of cell supernatant
- incubate cell supernatant at 65°C for 30min
- centrifuge cell supernatant for 1 min at 1250g
- add 80 µl supernatant into a 96 well plate
- add 100 µl 2x SEAP buffer
- add 20 µl pNPP and remove bubbles carefully
- measure in the plate reader every 30s for 2h
–> Experiment failed and will be repeated
05.08.17
Lentiviral Transduction
Puromycin killing curve
testing of untransfected JK cells and the scramble JK cells that have been transfected with the KO Kit (for each 5 conditions will be tested)
dilution of the Puro stock (10 mg/ml) 1:100 –> 100 µg/ml
cells will be distributed in a 12 well plate with 1 ml of media
concentration of Puro | volume from 100 µg/ml [µl] |
0 | 0 |
0.125 | 1.25 |
0.2 | 2 |
0.25 | 2.5 |
0.5 | 5 |
06.08.17
PEI for HRE-SEAP and CMV-SEAP; repetition of the SEAP assay
cells will be distributed in a 12 well plate on the next day
one master mix for PEI
1 ml DMEM, 30 µl PEI, 10 µg DNA per each approach
cotransfection of CMV-SEAP (95%) and HRE-SEAP (95%) with CMV-GFP (5%)
construct | concentration [ng/µl] | volume added for 9.5 µg [µl] |
HRE-SEAP | 248.2 | 38.3 |
CMV-SEAP | 415.2 | 22.9 |
construct | concentration [ng/µl] | volume added for 0.5 µg [µl] |
CMV-GFP | 303.1 | 1.6 |
BioRad Electroporation
Approach | plasmid | Capacitance[µF] | Voltage | Resistance | Time Constance [msec] |
1 | no Plasmid | 950 | 250 | ∞ | 20 |
2 | CMV-GFP | 950 | 250 | ∞ | 20 |
3 | CMV-GFP | 950 | 250 | ∞ | 20 |
4 | Ca construct | 950 | 250 | ∞ | 20 |
5 | Ca construct | 950 | 250 | ∞ | 20 |
6 | Ca construct | 950 | 250 | ∞ | 20 |
7 | Cas9-GFP-gRNA1 | 950 | 250 | ∞ | 20 |
8 | Cas9-GFP-gRNA1 | 950 | 250 | ∞ | 20 |
9 | Cas9-GFP-gRNA4 | 950 | 250 | ∞ | 20 |
10 | Cas9-GFP-gRNA4 | 950 | 250 | ∞ | 20 |
11 | Cas9-GFP-gRNA5 | 950 | 250 | ∞ | 20 |
12 | Cas9-GFP-gRNA5 | 950 | 250 | ∞ | 20 |
13 | Cas9-GFP-scramble | 950 | 250 | ∞ | 20 |
14 | Cas9-GFP-scramble | 950 | 250 | ∞ | 20 |
07.08.17
PEI for HRE-SEAP and CMV-SEAP; repetition of the SEAP assay
GFP was observed under the microscope
the cells were evenly distributed onto 12 well plates
induction with CoCl2 after the cells recovered from the transfer
8 conditions per approach, everything done in triplicates
concentration of CoCl2 [µM] | volume added [µl] |
0 | 0 |
100 | 0,5 |
150 | 0,75 |
200 | 1 |
250 | 1,25 |
300 | 1,5 |
500 | 2,5 |
1000 | 5 |
08.08.17
Lentivirus production in HEK cells: Mock, pIG17_133, pIG17_119, pIG17_121
PEI for HRE-SEAP and CMV-SEAP; repetition of the SEAP assay
The SEAP assay was negative. No changes in the OD for either CMV-SEAP or HRE-SEAP could be observed. Due to these troubles the next test will be postponed till all constructs have undergone another test digestion and sequencing.
10.08.17
Lentiviral transduction
Virus: pIG17_082, pIG17_119, pIG17_121 and pIG17_133
Plate 200000 virus for infection
As control: HEK with 1:1 infection
Cell Sorting: KO-plasmid transfected cells
11.08.17
BioRad Electroporation
Approach | plasmid | Capacitance[µF] | Voltage | Resistance | Time Constance [msec] |
1 | no Plasmid | 950 | 250 | ∞ | 20 |
2 | KO Kit 203+101 | 950 | 250 | ∞ | 20 |
3 | KO Kit 203+104 | 950 | 250 | ∞ | 20 |
4 | Lenti-Cas9-Puro | 950 | 250 | ∞ | 20 |
Puromycin killing curve
Day 6 after addition of puromycin: due to low cell numbers, the cells were spun down, resuspended in 100 µl and then counted.
Results for untransfected Jurkat cells and Jurkat cells transfected with the scramble:
Puromycin addition to the electroplated KO Kit cells
Approaches:
1x scramble no treatment
1x scramble 0.2 µg/ml
2x KO Kit 203+101 0.2 µg
2x KO Kit 203+104 0.2 µg
Transfer to a 6 well plate
12.08.17
Puromycin: electroplated KO Kit cells
Due to low cell counts the duplicates were pooled together and the cells transferred to a 12 well plate.
14.08.17
PEI: HRE-SEAP, pWW56
in 10cm plates:
10 µg DNA
1ml DMEM
30 µl PEI
approaches:
construct | concentration [ng/µl] | volume used for 10 µg DNA |
HRE-SEAP | 420,5 | 23,78 |
pWW56 | 555,5 | 18,00 |
15.08.17
SEAP
the cells were evenly distributed onto 12 well plates
induction with CoCl2 after the cells recovered from the transfer
8 conditions per approach, everything done in triplicates
concentration of CoCl2 [µM] | volume added [µl] |
0 | 0 |
100 | 0,5 |
150 | 0,75 |
200 | 1 |
250 | 1,25 |
300 | 1,5 |
500 | 2,5 |
1000 | 5 |
Electroporated KO Kit cells
Due to low cell counts the samples were transferred to a conical 96-well plate
BioRad Electroporation
Approach | plasmid | Capacitance[µF] | Voltage | Resistance | Time Constance [msec] |
1 | no Plasmid | 950 | 250 | ∞ | 20 |
2 | CMV-GFP + CMV-mCherry | 950 | 250 | ∞ | 20 |
3 | pIG17_086 | 950 | 250 | ∞ | 20 |
4 | pIG17_086 | 950 | 250 | ∞ | 20 |
Lentivirus Production in HEK cells
Approached by Frederike (AG Schamel)
2 Approaches (pIG17_119 & pIG17_121) with our HEK cells, envelope & packaging plasmid,PEI
1 Approach (pIG17_119) with material from AG Schamel: HEK, envelope & packaging plasmid, PEI
16.08.17
SEAP
The SEAP assay was performed as mentioned before, however, there was a 1:5 dilution included of the HRE-SEAP samples.
For the analysis of the SEAP assay, the averages of the triplicates were calculated and the respective wild-type control subtracted from the HRE-SEAP samples.
For the undiluted HRE-SEAP construct the following graph was obtained:
For the 1:5 dilution the following graph was obtained:
For the 1:5 dilution absorbance values are missing at the start because they were negative and therefore regarded as 0.
The positive control did not work due to the promoter of this construct which was dependent on an input that wasn't given.
Furthermore, the samples did not show what we expected, considering that the uninduced control showed a steeper slope than most of the samples. Due to this reason the experiment was repeated.
17.08.17
Lentiviral Transduction with virus-medium
Approaches for Titer test: both normal transduction and spin-infection.
On 8/20: After washing the cells, there was no signal from reporter gene expression.
23.08.17
PEI transfection of HEK cells for lentivirus production
25.08.17
Concentrate virus (pIG17_130)
Add 8 ml 20% Sucrose (in PBS + 1Mm EDTA) in 50 ml Falcon Tube
Add virus media slowly over sucrose (Use 25ml pippet)
Centrifuge over night at 4000 rpm, 4°C
26.08.17
Lentiviral Transduction (pIG17_130)
Plate 200000 cells/well (HEK & Jurkat) into 6 well plate
Titer of virus: 0, 15 µl, 30 µl
As shown in the picture the transduction of HEK cells showed high efficiency. The cells were also mycoplasma-negative, so that the cells can be sorted at Bioss.
The efficiency of transduction was quite low. The positive signal showed above may come from dead cells. New transduction was done on 8/30 with higher virus titer (45µl and 60µl).
Lentiviral transduction of Jurkat cells with higher virus titer showed higher efficiency than previous try. These cells are sent for microplasma-test and for cell sorting.
30.08.17
PEI transfection of HEK cells for lentivirus production (133&134)
02.09.17
PEI transfection of HEK cells for lentivirus production (132)
04.09.17
BioRad Electroporation
9µg for each approach
Number of approaches | Plasmid | Concentration [ng/µl] | Volume for 9ng [µl] | Capacitance[µF] | Voltage | Resistance | Time Constance [msec] |
1 | no DNA | 0 | 0 | 950 | 250 | ∞ | 20 |
1 | CMV GFP, CMV mCherry | 327.1, 1200 | 1376, 3.75 | 950 | 250 | ∞ | 20 |
2 | pIG17_031 | 746.9 | 12.05 | 950 | 250 | ∞ | 20 |
2 | pIG17_034 | 1210.9 | 7.43 | 950 | 250 | ∞ | 20 |
2 | pIG17_037 | 851.9 | 10.56 | 950 | 250 | ∞ | 20 |
05.09.17
Washing of the electroporated cells
06.09.17
07.09.17
Induction of the promoters
Set-up for pIG17_031 - hypoxia
- in a 96 well plate with 200 µl volume:
CoCl2 concentration [µM] | Number of approaches | Volume added [µl] |
0 | 1 | 0 |
50 | 2 | 0.5 |
100 | 2 | 1 |
200 | 2 | 2 |
400 | 2 | 4 |
800 | 2 | 8 |
.
Set-up for pIG17_034 - pH
- in a 96 well plate with 200 µl volume:
used concentration of NaOH: 1 M
used concentration of lactate: 0.6 M
used concentration of Forskolin: 10 mM
approximately 15000 cells per approach
Lactate (L), NaOH (N) or Forskolin (F) concentration or pH | Number of approaches | Volume added [µl] |
100 µM (F) | 1 | 2 |
8.17 pH (N) | 2 | 0.4 |
7.85 pH | 2 | 0 |
6.54 pH (L) | 2 | 8 |
6.19 pH (L) | 2 | 10.67 |
6 well plate with 3ml RPMI and the same concentration of lactate or NaOH as in the 96 well plate but without cells
used in order to measure the pH
amount of cells will be neglected as it is rather low
Set-up for pIG17_037 - VEGF
- in a 96 well plate with 200 µl volume:
VEGF concentration [ng/ml] | Number of approaches | Volume added [µl] |
0 | 1 | 0 |
2.5 | 2 | 0.5 |
5 | 2 | 1 |
10 | 2 | 2 |
20 | 2 | 4 |
40 | 2 | 8 |
27.08.17 - 07.09.17
Neomycin killing curve of Jurkat cells
11.09.17
PEI transfection of HEK cells for lenvirus production
Viafect - new testing
Jurkat cells with CMV-GFP; transfection mix:
12 well plate
2 mio cells per well in 500 µl medium
0.5 µg DNA per well
Viafect/DNA = 2:1 and 3:1
50 µl total volume per approach (filled up with serum free DMEM)
removal of the medium from pelleted cells
resuspending of pelleted cells in the transfection mix
addition of 500 µl RPMI 1649 with FCS after
0 seconds
4 seconds
8 seconds
16 seconds
32 seconds
transfer of the cell suspension to a 24 well plate
Analysis in the fluorescence microscope showed that this method did not work again
15.09.17
PEI transfection of HEK cells for lenvirus production
20.09.17
PEI transfection of HEK cells for lenvirus production
21.09.17
PEI transfection of HEK cells for SEAP assay
The set up for the SEAP assay was the same as before, however there wild-type controls with the same amount of CoCl2 included.
All samples were done in triplicates
22.09.17
SEAP assay
Induction with CoCl2, the used concentrations of CoCl2 were: 0, 20, 40, 80, 160, 320 and 640 µM.
23.09.17
SEAP assay
The SEAP assay was performed as before, this time we included a cell count of each pooled triplicate.
For the analysis first the averages of the triplicates were calculated and then divided by the cell count. Afterwards, the corresponding wild-type control was subtracted from the samples and all negative values were set to 0.
We could see that only 20, 40 and 80 µM CoCl2 showed a steeper slope in our samples than the 0 µM control.
24.09.17
PEI transfection of HEK cells for lenvirus production
24.09.17
HRE testing with stable HEK cell lines
04.10.17
PEI transfection of HEK cells for lenvirus production
09.10.17
CFP test
Due to the problems with our GFP readout we performed a search in BLAST and found out that our eGFP was wrongly annotate and is a eCFP. We also could see that in the FACS. For this we tested our Jurkat knockdown 130 cells, that stably express CFP then. On the left these cells are measured in the CFP channel and on the right in the GFP channel. The depicted cells are gated for living and single cells:
There is a clear shift and our cells are really CFP positive and not GFP positive
CRE Test in Jurkat cells
With Forskolin and IBMX, the cAMP pathway in the cell is activated.
Cell lines: WT Jurkat, stable CRE4X Jurkat
Conditions: untreated, induction with 100 µM Forskolin, induction with 100 µM IBMX, induction with 100 µM Forskolin and 100 µM IBMX.
FACS:
Cells were gated for living, single, mCherry positive cells and then the amount of CFP positive cells was measured:
10.10.17
HRE Test in Jurkat cells
HRE Test in HEK cells
12.10.17
CRE Test in HEK cells
CRE Test in Jurkat cells
We obtained the following results after gating for living, single, mCherry positive cells:
VEGF Test in HEK cells